↓ Skip to main content

Cochrane Database of Systematic Reviews

Pharmacological treatment of depression in patients with a primary brain tumour

Overview of attention for article published in Cochrane database of systematic reviews, May 2013
Altmetric Badge

Mentioned by

twitter
1 X user

Citations

dimensions_citation
46 Dimensions

Readers on

mendeley
106 Mendeley
Title
Pharmacological treatment of depression in patients with a primary brain tumour
Published in
Cochrane database of systematic reviews, May 2013
DOI 10.1002/14651858.cd006932.pub3
Pubmed ID
Authors

Alasdair G Rooney, Robin Grant

Abstract

This is an updated version of the original Cochrane review published in Issue 3, 2010.Patients with a primary brain tumour often experience depression, for which drug treatment may be prescribed. However, these patients are also at high risk of epileptic seizures, cognitive impairment and fatigue, all of which are potential side effects of antidepressants. The benefit, or harm, of pharmacological treatment of depression in brain tumour patients is unclear.

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 106 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Spain 1 <1%
Norway 1 <1%
Unknown 104 98%

Demographic breakdown

Readers by professional status Count As %
Student > Master 16 15%
Student > Bachelor 16 15%
Researcher 12 11%
Student > Doctoral Student 12 11%
Student > Ph. D. Student 7 7%
Other 21 20%
Unknown 22 21%
Readers by discipline Count As %
Medicine and Dentistry 30 28%
Psychology 15 14%
Nursing and Health Professions 13 12%
Pharmacology, Toxicology and Pharmaceutical Science 4 4%
Social Sciences 4 4%
Other 11 10%
Unknown 29 27%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 31 May 2013.
All research outputs
#20,723,696
of 25,457,858 outputs
Outputs from Cochrane database of systematic reviews
#10,914
of 11,842 outputs
Outputs of similar age
#157,356
of 207,187 outputs
Outputs of similar age from Cochrane database of systematic reviews
#260
of 279 outputs
Altmetric has tracked 25,457,858 research outputs across all sources so far. This one is in the 10th percentile – i.e., 10% of other outputs scored the same or lower than it.
So far Altmetric has tracked 11,842 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 38.9. This one is in the 1st percentile – i.e., 1% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 207,187 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 12th percentile – i.e., 12% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 279 others from the same source and published within six weeks on either side of this one. This one is in the 2nd percentile – i.e., 2% of its contemporaries scored the same or lower than it.